(Q38974682)

English

ZEB1 knockdown mediated using polypeptide cationic micelles inhibits metastasis and effects sensitization to a chemotherapeutic drug for cancer therapy

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ZEB1 knockdown mediated using polypeptide cationic micelles inhibits metastasis and effects sensitization to a chemotherapeutic drug for cancer therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Shengtao Fang

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lei Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Mingxing Li

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Huqiang Yi

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Guanhui Gao

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Zonghai Sheng

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ping Gong

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yifan Ma

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lintao Cai

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

10084-10094

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Lentivirus-delivered ZEB-1 small interfering RNA inhibits lung adenocarcinoma cell growth in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Concept and clinical evaluation of carrier-mediated anticancer agents

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Self-assembled cationic micelles based on PEG-PLL-PLLeu hybrid polypeptides as highly effective gene vectors

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Molecular requirements for epithelial-mesenchymal transition during tumor progression

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs

1 reference

https://api.crossref.org/works/10.1039%2FC4NR01518E

21 January 2018

Identifiers

10.1039/C4NR01518E

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

release_jhlrp7crjrc7fay4mgax3tmh7m

1 reference

https://api.fatcat.wiki/v0/release/jhlrp7crjrc7fay4mgax3tmh7m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38974682&oldid=1843476885"